| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.00021 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.00011 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -3.2e-05 | 1 |